HELVIG, CHRISTIAN F.,PETKOVICH, P. MARTIN,TABASH, SAMIR P.
申请号：
CA2683628
公开号：
CA2683628C
申请日:
2008.04.25
申请国别(地区):
CA
年份:
2018
代理人:
摘要：
The disclosure relates generally to methods, kits, and dosage forms forreducing toxicity associated with treatment using vitamin D3, the pro-hormone25-hydroxyvitaminD3, active hormone 1,25-dihydroxyvitamin D3 or vitamin D3 analogs(including hydroxy and dihydroxy forms). The methods, kits, and dosage formscomprise a vitamin D3 supplement and a vitamin D2 supplement, wherein at leastoneof the vitamin D3 supplement and the vitamin D2 supplement is a 25-hydroxyvitaminD compound.
